OP increases with intravitreal bevacizumab injection, reaching 50 mmHg or more in about one third of patients. A higher IOP is expected if no subconjunctival reflux occurs. The baseline IOP does not influence the incidence of subconjunctival reflux. The clinical relevance of these facts has yet to be clarified.
Thursday, August 07, 2014
INTRAOCULAR (IOP) PRESSURE INCREASE IN BEVACIZUMAB INJECTIONS
Clinical Ophthalmology:
Subscribe to:
Post Comments (Atom)
Would have been interesting to document how long it takes for the IOP to normalize
ReplyDelete